These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34010151)
21. Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis. Chai YJ; Kim YA; Jee HG; Yi JW; Jang BG; Lee KE; Park YJ; Youn YK Surgery; 2014 Dec; 156(6):1559-67; discussion 1567-8. PubMed ID: 25456955 [TBL] [Abstract][Full Text] [Related]
22. Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis. Zeng Y; Zhang J; Xu M; Chen F; Zi R; Yue J; Zhang Y; Chen N; Chin YE J Cancer; 2021; 12(19):5888-5894. PubMed ID: 34476002 [TBL] [Abstract][Full Text] [Related]
23. SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma. Ning S; Ma S; Saleh AQ; Guo L; Zhao Z; Chen Y Gastroenterol Res Pract; 2018; 2018():4369253. PubMed ID: 30228815 [TBL] [Abstract][Full Text] [Related]
24. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells. Ji L; Tang Y; Pang X; Zhang Y Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360 [TBL] [Abstract][Full Text] [Related]
25. Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like. Giannini R; Moretti S; Ugolini C; Macerola E; Menicali E; Nucci N; Morelli S; Colella R; Mandarano M; Sidoni A; Panfili M; Basolo F; Puxeddu E J Clin Endocrinol Metab; 2019 Aug; 104(8):3557-3575. PubMed ID: 30882858 [TBL] [Abstract][Full Text] [Related]
26. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma. Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674 [TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of five miRNAs in papillary thyroid carcinomas. Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792 [TBL] [Abstract][Full Text] [Related]
28. Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses. Lee SE; Park S; Yi S; Choi NR; Lim MA; Chang JW; Won HR; Kim JR; Ko HM; Chung EJ; Park YJ; Cho SW; Yu HW; Choi JY; Yeo MK; Yi B; Yi K; Lim J; Koh JY; Lee MJ; Heo JY; Yoon SJ; Kwon SW; Park JL; Chu IS; Kim JM; Kim SY; Shan Y; Liu L; Hong SA; Choi DW; Park JO; Ju YS; Shong M; Kim SK; Koo BS; Kang YE Nat Commun; 2024 Feb; 15(1):1163. PubMed ID: 38331894 [TBL] [Abstract][Full Text] [Related]
29. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. Landa I; Ibrahimpasic T; Boucai L; Sinha R; Knauf JA; Shah RH; Dogan S; Ricarte-Filho JC; Krishnamoorthy GP; Xu B; Schultz N; Berger MF; Sander C; Taylor BS; Ghossein R; Ganly I; Fagin JA J Clin Invest; 2016 Mar; 126(3):1052-66. PubMed ID: 26878173 [TBL] [Abstract][Full Text] [Related]
31. Down-Regulation of APTR and it's Diagnostic Value in Papillary and Anaplastic Thyroid Cancer. Zhang K; Li C; Liu J; Li Z; Ma C Pathol Oncol Res; 2020 Jan; 26(1):559-565. PubMed ID: 30539519 [TBL] [Abstract][Full Text] [Related]
32. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants. Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918 [TBL] [Abstract][Full Text] [Related]
33. Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer. Wang Y; Jin Y; Bhandari A; Yao Z; Yang F; Pan Y; Zheng Z; Lv S; Wang O Onco Targets Ther; 2018; 11():37-46. PubMed ID: 29317832 [TBL] [Abstract][Full Text] [Related]
34. Silencing SHMT2 inhibits the progression of tongue squamous cell carcinoma through cell cycle regulation. Liao Y; Wang F; Zhang Y; Cai H; Song F; Hou J Cancer Cell Int; 2021 Apr; 21(1):220. PubMed ID: 33863325 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer. Tan J; Liu L; Zuo Z; Song B; Cai T; Ding D; Lu Y; Ye X Oncol Rep; 2020 Oct; 44(4):1489-1501. PubMed ID: 32945494 [TBL] [Abstract][Full Text] [Related]
36. Use of sodium iodide symporter expression in differentiated thyroid carcinomas. Morari EC; Marcello MA; Guilhen AC; Cunha LL; Latuff P; Soares FA; Vassallo J; Ward LS Clin Endocrinol (Oxf); 2011 Aug; 75(2):247-54. PubMed ID: 21521301 [TBL] [Abstract][Full Text] [Related]
37. Deregulated expression of VHL mRNA variants in papillary thyroid cancer. Baldini E; Tuccilli C; Arlot-Bonnemains Y; Chesnel F; Sorrenti S; De Vito C; Catania A; D'Armiento E; Antonelli A; Fallahi P; Watutantrige-Fernando S; Tartaglia F; Barollo S; Mian C; Bononi M; Arceri S; Mascagni D; Vergine M; Pironi D; Monti M; Filippini A; Ulisse S Mol Cell Endocrinol; 2017 Mar; 443():121-127. PubMed ID: 28089820 [TBL] [Abstract][Full Text] [Related]
38. Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance. Kim HS; Choi JH; Lee JY; Kang J; Myung JK; Kim WH; Jang BG Sci Rep; 2020 Mar; 10(1):4853. PubMed ID: 32184420 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature. Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837 [TBL] [Abstract][Full Text] [Related]